Key facts
- It has raised $17.6M; the latest was Accelerator/Incubator ($500K) in Sep 2025.
- Notable investors include Google for Startups, Accelerate Cambridge, PFR Ventures, Verge Capital Management, Aligo Venture Capital — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Prosoma
- ·The full record, as it builds
Funding rounds
No funding rounds for Prosoma are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Prosoma
Provider of digital therapeutics intended to support the psychological and behavioral needs of cancer patients. The company's platform delivers clinically validated, real-time psycho-oncological care, reducing stress, anxiety, and depression while improving emotional functioning and overall treatment outcomes, enabling healthcare providers, patients, and insurers to enhance quality of life and achieve better recovery results.
- Sector
- Healthcare
- HQ
- Wrocław, Poland
- Founded
- 2017
- Employees
- 37
- Website
- prosoma.com/
- Ownership
- Privately Held (backing)
Prosoma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Prosoma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Prosoma in its N-PORT filings yet. We sweep new filings monthly.